Your browser doesn't support javascript.
loading
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.
Jamshidi, Maral; Fagerholm, Rainer; Khan, Sofia; Aittomäki, Kristiina; Czene, Kamila; Darabi, Hatef; Li, Jingmei; Andrulis, Irene L; Chang-Claude, Jenny; Devilee, Peter; Fasching, Peter A; Michailidou, Kyriaki; Bolla, Manjeet K; Dennis, Joe; Wang, Qin; Guo, Qi; Rhenius, Valerie; Cornelissen, Sten; Rudolph, Anja; Knight, Julia A; Loehberg, Christian R; Burwinkel, Barbara; Marme, Frederik; Hopper, John L; Southey, Melissa C; Bojesen, Stig E; Flyger, Henrik; Brenner, Hermann; Holleczek, Bernd; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Van Dyck, Laurien; Nevelsteen, Ines; Couch, Fergus J; Olson, Janet E; Giles, Graham G; McLean, Catriona; Haiman, Christopher A; Henderson, Brian E; Winqvist, Robert; Pylkäs, Katri; Tollenaar, Rob A E M; García-Closas, Montserrat; Figueroa, Jonine; Hooning, Maartje J; Martens, John W M; Cox, Angela; Cross, Simon S; Simard, Jacques.
Afiliação
  • Jamshidi M; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, HUS, Finland.
  • Fagerholm R; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, HUS, Finland.
  • Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, HUS, Finland.
  • Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, HUS, Finland.
  • Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Chang-Claude J; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Devilee P; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
  • Fasching PA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Michailidou K; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bolla MK; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Dennis J; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Wang Q; Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
  • Guo Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Cornelissen S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Rudolph A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Knight JA; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Loehberg CR; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Burwinkel B; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Marme F; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hopper JL; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Southey MC; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Bojesen SE; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Flyger H; Molecular Epidemiology Group, German Cancer Research Center, Heidelberg, Germany.
  • Brenner H; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Holleczek B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Margolin S; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Mannermaa A; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kosma VM; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Van Dyck L; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Nevelsteen I; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Couch FJ; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Olson JE; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Giles GG; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • McLean C; Saarland Cancer Registry, Saarbrücken, Germany.
  • Haiman CA; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Henderson BE; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Winqvist R; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Pylkäs K; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Tollenaar RA; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • García-Closas M; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Figueroa J; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  • Martens JW; Vesalius Research Center (VRC), VIB, Leuven, Belgium.
  • Cox A; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
  • Cross SS; Multidisciplinary Breast Center, Medical Oncology, University Hospital Leuven, Leuven, Belgium.
  • Simard J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Oncotarget ; 6(35): 37979-94, 2015 Nov 10.
Article em En | MEDLINE | ID: mdl-26317411
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transdução de Sinais / Biomarcadores Tumorais / NF-kappa B / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transdução de Sinais / Biomarcadores Tumorais / NF-kappa B / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia